Benefits of a very low energy diet in patients with PsA and concomitant obesity June 22, 2022Psoriatic Arthritis
PsA: MCP-1 may serve as a biomarker in identifying isolated asymptomatic diastolic dysfunctionJune 22, 2022Psoriatic Arthritis
Higher prevalence of cardiovascular risk factors and cardiovascular events in PsAJune 22, 2022Psoriatic Arthritis
Presence of crystals in synovial fluid tied with higher disease burden in PsAJune 22, 2022Psoriatic Arthritis
Current psoriatic lesions or a personal history of psoriasis correlates with PsA disease activityJune 22, 2022Psoriatic Arthritis
Real-world study confirms benefits of golimumab on work productivity and QoL in PsAJune 22, 2022Psoriatic Arthritis
Rheumatology NewsBimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trialsJune 15, 2022Psoriatic Arthritis
Rheumatology NewsIzokibep improves multiple psoriatic arthritis symptoms in phase 2 studyJune 5, 2022Psoriatic Arthritis
Rheumatology NewsSerum brodalumab levels linked with treatment outcomes in patients with psoriasisJune 2, 2022Psoriatic Arthritis
Commentary: Factors in Psoriatic Arthritis Development and Treatment Response, June 2022June 1, 2022Psoriatic Arthritis
